SECTION 3

Diversity Strategies

Regulators increasingly require more diverse trials. In this section, we outline why you need to plan your diversity strategy early, discuss our research on barriers to trial participation, explore more equitable reimbursement for research participants, and report on patients' and sites' perceptions of clinical research in China.

Download the executive summary of the full report